Target General Infomation
Target ID
T39321
Former ID
TTDR00995
Target Name
Glyceraldehyde 3-phosphate dehydrogenase, muscle
Gene Name
GAPDH
Synonyms
D-glyceraldehyde-3-phosphate dehydrogenase; GAPDH
Target Type
Clinical Trial
Disease Lateral sclerosis [ICD10: G12.2]
Function
Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby playing a role in glycolysis and nuclear functions, respectively. Participates in nuclear events including transcription, RNA transport, DNA replication and apoptosis. Nuclear functions are probably due to the nitrosylase activity that mediates cysteine S-nitrosylation of nuclear target proteins such as SIRT1, HDAC2 and PRKDC. Modulates the organization and assembly of the cytoskeleton. Facilitates the CHP1-dependent microtubule and membrane associations through its ability to stimulate the binding of CHP1 to microtubules (By similarity). Glyceraldehyde-3-phosphate dehydrogenase is a key enzyme in glycolysis that catalyzes the first step of the pathway by converting D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D- glyceroylphosphate. Component of the GAIT (gamma interferon- activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma treatment assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation.
BioChemical Class
Glyceraldehyde-3-phosphate
UniProt ID
EC Number
EC 2.6.99.-
Sequence
MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTV
KAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVI
ISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHA
ITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANV
SVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAG
IALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE
Drugs and Mode of Action
Drug(s) Omigapil Drug Info Phase 2 Lateral sclerosis [522278]
Modulator Omigapil Drug Info [528054]
Binder Saframycin A Drug Info [535941]
Target Expression Profile (TEP) and Drug Resistance Mutation (DRM)
TEP EXP Info
Pathways
BioCyc Pathway Superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle
Gluconeogenesis
NADH repair
Glycolysis
KEGG Pathway Glycolysis / Gluconeogenesis
Metabolic pathways
Biosynthesis of antibiotics
Carbon metabolism
Biosynthesis of amino acids
HIF-1 signaling pathway
Alzheimer&#039
s disease
NetPath Pathway TCR Signaling Pathway
IL2 Signaling Pathway
TSH Signaling Pathway
PANTHER Pathway Glycolysis
Huntington disease
Pathway Interaction Database Validated targets of C-MYC transcriptional activation
PathWhiz Pathway Glycerol Phosphate Shuttle
Glycolysis
Gluconeogenesis
Mitochondrial Electron Transport Chain
Warburg Effect
Reactome Glycolysis
Gluconeogenesis
WikiPathways SIDS Susceptibility Pathways
Glycolysis and Gluconeogenesis
Alzheimers Disease
Cori Cycle
References
Ref 522278ClinicalTrials.gov (NCT00649961) Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study. U.S. National Institutes of Health.
Ref 528054Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3887-9. Epub 2006 Feb 27.
Ref 535941Identification of GAPDH as a protein target of the saframycin antiproliferative agents. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5862-6. Epub 2004 Apr 12.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.